NF1-Associated PN Community Insights: Key Questions, Expert Answers
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Related Articles
Sequential Bortezomib and Temozolomide: An Option for Recurrent Glioblastoma?
Sequential treatment with bortezomib and temozolomide provides a clinical benefit in patients with MGMT-unmethylated glioblastoma, according to researchers.
2024 ARP Master Designation
Each year, the Association of Rheumatology Professionals (ARP) recognizes its membersβ outstanding contributions to the field of rheumatology through an awar…
Program
Explore the program for the AACR Special Conference in Cancer Research: Translating Targeted Therapies in Combination with Radiotherapy.
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
Key PointsDaratumumab plus chemotherapy may effectively bridge children and young adults with relapsed/refractory T-cell ALL/LL to HSCT.No new safety conce
FDA approves revumenib for r/r acute leukemia with a KMT2A translocation – The Cancer Letter
FDA approved revumenib (Revuforj, Syndax Pharmaceuticals, Inc.), a menin inhibitor, for relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in…
Welcome! You are invited to join a webinar: Post-ASH 2024 CLL highlights webinar. After registering, you will receive a confirmation email about joining the webinar.
Join us to watch leading CLL experts present summaries on the most significant abstracts from ASH 2024 followed by interactive panel discussions debating current clinical…
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18) | Journal of Clinical Oncology
PURPOSETo investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-free survival (PFS),…
NF1-Associated PN Community Insights: Key Questions, Expert Answers
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.
IASLC’s Regional Course Series | IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and…
